Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjorn Nashan

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Transplantation|June 26, 2003
Review of T-cell activation: impact of Janus kinase 3 inhibitionBjorn Nashan
Frontiers in Pharmacology|November 7, 2022
Involvement of endoplasmic reticulum stress in rifampicin-induced liver injuryWanqing Hou, Bernard Nsengimana, Chuyun Yan, et al.
Transplantation|August 22, 2009
Contribution of B cells and antibody to cardiac allograft vasculopathyAlison Gareau, Gregory M Hirsch, Tim D G Lee, et al.
World Journal of Clinical Oncology|June 30, 2025
Efficacy of salvage surgery for hepatocellular carcinoma following conversion therapyShao-Bo Zhang, Bjorn Nashan, Yan-Li Wang, et al.
Trials|April 16, 2015
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trialBjorn Nashan, Peter Schemmer, Felix Braun, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 5, 2012
Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathyAlison J Gareau, Bjorn Nashan, Gregory M Hirsch, et al.
Transplantation|May 24, 2007
Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patientsClary J Foote, Wenda Greer, Bryce Kiberd, et al.
Clinical Transplants|May 18, 2006
The year in review--2004Philip Belitsky, Bjorn Nashan, Bryce Kiberd, et al.
Cellular Signalling|July 27, 2015
Discontinuing MEK inhibitors in tumor cells with an acquired resistance increases migration and invasionDominik Nörz, Astrid Grottke, Johanna Bach, et al.
Clinical Transplants|September 16, 2003
Expansion of the donor pool in liver transplantation: the Hannover experience 1996-2002Bjorn Nashan, Rainer Lück, Thomas Becker, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Transplantation|June 26, 2003
Review of T-cell activation: impact of Janus kinase 3 inhibitionBjorn Nashan
Frontiers in Pharmacology|November 7, 2022
Involvement of endoplasmic reticulum stress in rifampicin-induced liver injuryWanqing Hou, Bernard Nsengimana, Chuyun Yan, et al.
Transplantation|August 22, 2009
Contribution of B cells and antibody to cardiac allograft vasculopathyAlison Gareau, Gregory M Hirsch, Tim D G Lee, et al.
World Journal of Clinical Oncology|June 30, 2025
Efficacy of salvage surgery for hepatocellular carcinoma following conversion therapyShao-Bo Zhang, Bjorn Nashan, Yan-Li Wang, et al.
Trials|April 16, 2015
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trialBjorn Nashan, Peter Schemmer, Felix Braun, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 5, 2012
Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathyAlison J Gareau, Bjorn Nashan, Gregory M Hirsch, et al.
Transplantation|May 24, 2007
Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patientsClary J Foote, Wenda Greer, Bryce Kiberd, et al.
Clinical Transplants|May 18, 2006
The year in review--2004Philip Belitsky, Bjorn Nashan, Bryce Kiberd, et al.
Cellular Signalling|July 27, 2015
Discontinuing MEK inhibitors in tumor cells with an acquired resistance increases migration and invasionDominik Nörz, Astrid Grottke, Johanna Bach, et al.
Clinical Transplants|September 16, 2003
Expansion of the donor pool in liver transplantation: the Hannover experience 1996-2002Bjorn Nashan, Rainer Lück, Thomas Becker, et al.
Pageof 2